Gyre Therapeutics (GYRE) Interest Coverage Ratio (2010 - 2024)
Gyre Therapeutics (GYRE) reported Interest Coverage Ratio of 25.62 for Q1 2024, up 147.23% year-over-year from 10.36 in Q2 2023, and up 147.23% quarter-over-quarter from 10.36 in Q1 2023.
Gyre Therapeutics (GYRE) Interest Coverage Ratio (2010 - 2024) Analysis & Trends
Gyre Therapeutics (GYRE) has 10 years of Interest Coverage Ratio data on file, last reported at 25.62 in Q1 2024.
- Interest Coverage Ratio for Q1 2024 came in at 25.62, up 147.23% year-over-year; the trailing twelve-month figure through Dec 2024 was 51.31 (up 149.07% YoY), and the FY2023 annual result was 25.92, down 486.95% from the prior year.
- Interest Coverage Ratio improved to 25.62 in Q1 2024 per GYRE's latest filing, from 10.36 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 25.62 in Q1 2024 and troughed at 2300.0 in Q3 2020.
- A 3-year average of 632.35 and a median of 127.5 in 2020 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2020 and 2024: Interest Coverage Ratio plunged 164.51% in 2020, then surged 147.23% in 2024.
- A 3-year view of Interest Coverage Ratio shows it stood at 265.37 in 2020, then surged by 103.91% to 10.36 in 2023, then surged by 147.23% to 25.62 in 2024.
- Business Quant data shows GYRE's Interest Coverage Ratio at 25.62 in Q1 2024, 10.36 in Q1 2023, and 265.37 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 25.62 |
| Mar 31, 2023 | 10.36 |
| Dec 31, 2020 | -265.37 |
| Sep 30, 2020 | -2,300.00 |
| Dec 31, 2019 | 411.38 |
| Dec 31, 2015 | -3.40 |
| Jun 30, 2015 | -56.44 |
| Dec 31, 2014 | -599.33 |
| Sep 30, 2014 | -327.60 |
| Jun 30, 2014 | -368.33 |
| Mar 31, 2014 | -207.00 |
| Dec 31, 2013 | -1,330.80 |
| Sep 30, 2013 | -1,011.23 |
| Jun 30, 2013 | -892.00 |
| Mar 31, 2013 | -517.13 |
| Dec 31, 2012 | -903.33 |
| Sep 30, 2012 | -404.90 |
| Jun 30, 2012 | 647.00 |
| Mar 31, 2012 | 76.38 |
| Dec 31, 2011 | -307.42 |